Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Febuxostat was associated with a nearly 3-fold higher risk of mild to moderate perturbation of liver function than benzbromarone.

Higher Hepatotoxicity Risk With Febuxostat Over Benzbromarone in People With Gout

Significant associations were seen in males, Mexican Americans, married individuals, those with insufficient physical activity, and those with diabetes. 

Monocyte-to-HDL-C Ratio Correlated With Gout Risk and Renal Injury 

More studies are needed to assess whether creatinine or and hyperuricemia may be prognostic factors for these patients.

Creatinine Predicts Hyperuricemia in Patients With Breast Cancer

Dual-energy computed tomography results in faster dissolution of both the core and crown of tophi.

Research Shows Ultrasound Less Effective than DECT at Removing Tophi

Despite common practice avoiding benzbromarone, new data suggest it has a relatively low hepatotoxicity versus its more common counterpart in gout.

Febuxostat More Hepatotoxic than Benzbromarone in Gout, Study Finds

Our Q1 2025 recap for rheumatology spotlights 5 regulatory updates, 5 key trial announcements, and top expert perspectives in rheumatology care.

Q1 2025 Recap: Rheumatology News and Updates

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and psoriatic arthritis.

Rheumatology Month in Review: March 2025

By 3 months, nearly all patients confirmed exposed to 30 or 60 mg SAP-001 reached serum uric acid levels below 6mg/dL.

SAP-001 Demonstrates “Best in Class” Data for Gout With Hyperuricemia Refractory to SOC XOI Therapy

Other risk factors in the population included PZA or ETB use, hypertension, heart failure, and chronic kidney disease.

Patients With Tuberculosis at Increased Risk of Gout

MCP-1 and OPN combined had an AUC of 0.938 in diagnosing early renal injury.

Serum MCP-1 and OPN Combination May Help Diagnose Early Renal Injury in Gout  

On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.